Alginate/Pluronic F127-based encapsulation supports viability and functionality of human dental pulp stem cell-derived insulin-producing cells.

Alginate Dental pulp stem cells (DPSCs) Diabetes mellitus Encapsulation Insulin-producing cells (IPCs) Pluronic F127

Journal

Journal of biological engineering
ISSN: 1754-1611
Titre abrégé: J Biol Eng
Pays: England
ID NLM: 101306640

Informations de publication

Date de publication:
2020
Historique:
received: 24 04 2020
accepted: 13 08 2020
entrez: 29 8 2020
pubmed: 29 8 2020
medline: 29 8 2020
Statut: epublish

Résumé

Current approach for diabetes treatment remained several adverse events varied from gastrointestinal to life-threatening symptoms. Regenerative therapy regarding Edmonton protocol has been facing serious limitations involving protocol efficiency and safety. This led to the study for alternative insulin-producing cell (IPC) resource and transplantation platform. In this study, evaluation of encapsulated human dental pulp-derived stem cell (hDPSC)-derived IPCs by alginate (ALG) and pluronic F127-coated alginate (ALGPA) was performed. The results showed that ALG and ALGPA preserved hDPSC viability and allowed glucose and insulin diffusion in and out. ALG and ALGPA-encapsulated hDPSC-derived IPCs maintained viability for at least 336 h and sustained pancreatic endoderm marker ALG and ALGPA encapsulations efficiently preserved the viability and functionality of hDPSC-derived IPCs in vitro and could be the potential transplantation platform for further clinical application.

Sections du résumé

BACKGROUND BACKGROUND
Current approach for diabetes treatment remained several adverse events varied from gastrointestinal to life-threatening symptoms. Regenerative therapy regarding Edmonton protocol has been facing serious limitations involving protocol efficiency and safety. This led to the study for alternative insulin-producing cell (IPC) resource and transplantation platform. In this study, evaluation of encapsulated human dental pulp-derived stem cell (hDPSC)-derived IPCs by alginate (ALG) and pluronic F127-coated alginate (ALGPA) was performed.
RESULTS RESULTS
The results showed that ALG and ALGPA preserved hDPSC viability and allowed glucose and insulin diffusion in and out. ALG and ALGPA-encapsulated hDPSC-derived IPCs maintained viability for at least 336 h and sustained pancreatic endoderm marker
CONCLUSION CONCLUSIONS
ALG and ALGPA encapsulations efficiently preserved the viability and functionality of hDPSC-derived IPCs in vitro and could be the potential transplantation platform for further clinical application.

Identifiants

pubmed: 32855655
doi: 10.1186/s13036-020-00246-1
pii: 246
pmc: PMC7446208
doi:

Types de publication

Journal Article

Langues

eng

Pagination

23

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

Diabetes Res Clin Pract. 2018 Apr;138:271-281
pubmed: 29496507
J Biomater Sci Polym Ed. 2001;12(9):1051-8
pubmed: 11787521
Biosci Rep. 2019 May 21;39(5):
pubmed: 31015367
Methods Mol Biol. 2020;2100:473-491
pubmed: 31939144
Endocr Pract. 2015 Apr;21 Suppl 1:1-87
pubmed: 25869408
Mol Med Rep. 2015 May;11(5):3269-78
pubmed: 25591506
Cell Med. 2019 Sep 13;11:2155179019876641
pubmed: 34557325
Front Bioeng Biotechnol. 2019 Dec 03;7:380
pubmed: 31850335
Front Pharmacol. 2020 Jan 24;10:1576
pubmed: 32038250
Lancet. 2011 Jul 2;378(9785):31-40
pubmed: 21705069
PLoS One. 2016 Oct 18;11(10):e0164457
pubmed: 27755557
Genomics Proteomics Bioinformatics. 2013 Oct;11(5):284-7
pubmed: 24121200
Differentiation. 2009 Jun;77(5):483-91
pubmed: 19505629
Drug Discov Today. 2019 Mar;24(3):737-748
pubmed: 30738185
Front Vet Sci. 2020 Feb 12;7:4
pubmed: 32118053
World J Stem Cells. 2015 Jan 26;7(1):174-81
pubmed: 25621117
Stem Cells Transl Med. 2017 Jul;6(7):1631-1643
pubmed: 28467694
Heliyon. 2020 Jan 06;6(1):e03054
pubmed: 32042932
Toxicol In Vitro. 2015 Feb;29(1):124-31
pubmed: 25300790
Cell J. 2015 Summer;17(2):304-11
pubmed: 26199909
Sci Rep. 2014 Oct 31;4:6856
pubmed: 25358640
Cytotherapy. 2005;7(5):393-5
pubmed: 16236628
J Immunol Methods. 1994 Apr 15;170(2):211-24
pubmed: 8157999
Eur Cell Mater. 2011 Jan 25;21:94-106
pubmed: 21267945
Reprod Biomed Online. 2012 Feb;24(2):235-46
pubmed: 22196893
Int J Pharm. 2009 May 21;373(1-2):85-92
pubmed: 19429292
Diabetes. 2017 Jul;66(7):1748-1754
pubmed: 28637827
Dev Reprod. 2017 Mar;21(1):1-10
pubmed: 28484739
Stem Cell Res Ther. 2017 Sep 29;8(1):199
pubmed: 28962589
Turk J Biol. 2018 Aug 9;42(4):297-306
pubmed: 30814893
Adv Healthc Mater. 2015 Sep 16;4(13):1961-71
pubmed: 26129820
Methods Mol Biol. 2017;1506:259-271
pubmed: 27830559
Stem Cells Int. 2016;2016:9305986
pubmed: 26798366
J Mater Sci Mater Med. 2015 Mar;26(3):153
pubmed: 25773231
Front Bioeng Biotechnol. 2014 Aug 06;2:26
pubmed: 25147785
Stem Cells. 2009 Aug;27(8):1941-53
pubmed: 19544426
N Engl J Med. 2006 Sep 28;355(13):1318-30
pubmed: 17005949
Nat Commun. 2019 Nov 20;10(1):5262
pubmed: 31748525
Nat Biotechnol. 2015 Jan;33(1):58-63
pubmed: 25437882
Biomed Res Int. 2015;2015:965804
pubmed: 26078974
Tissue Eng Part A. 2014 Dec;20(23-24):3198-211
pubmed: 24881778
J Endod. 2010 Sep;36(9):1504-15
pubmed: 20728718
J Vis Exp. 2012 Nov 24;(69):
pubmed: 23208006
Int J Biol Macromol. 2015;78:72-8
pubmed: 25847839
Ann N Y Acad Sci. 2014 Apr;1311:124-37
pubmed: 24611778
Curr Gene Ther. 2012 Oct;12(5):410-6
pubmed: 22920683
J Cell Physiol. 2019 May;234(5):6801-6809
pubmed: 30317587
Biochem Biophys Res Commun. 2014 Sep 26;452(3):581-7
pubmed: 25181343
J Vis Exp. 2017 Jun 29;(124):
pubmed: 28715390
Rev Diabet Stud. 2010 Summer;7(2):168-82
pubmed: 21060975
Indian J Endocrinol Metab. 2013 Sep;17(5):819-34
pubmed: 24083163
Stem Cells Dev. 2014 Jul 1;23(13):1479-90
pubmed: 24564648
Stem Cell Res Ther. 2019 Sep 23;10(1):293
pubmed: 31547868
Adv Drug Deliv Rev. 2019 Jan 15;139:92-115
pubmed: 29719210
Rev Diabet Stud. 2014 Spring;11(1):19-34
pubmed: 25148365
J Tissue Eng Regen Med. 2017 Dec;11(12):3469-3480
pubmed: 28568973
Am J Transplant. 2019 Jul;19(7):1930-1940
pubmed: 30748094
J Biotechnol. 2009 Dec;144(4):304-12
pubmed: 19686786
ACS Nano. 2017 Oct 24;11(10):9738-9749
pubmed: 28929735
In Vivo. 2009 Nov-Dec;23(6):929-35
pubmed: 20023235
Sci Rep. 2020 Jan 15;10(1):414
pubmed: 31942009
Am J Transplant. 2016 Feb;16(2):509-17
pubmed: 26433206

Auteurs

Suryo Kuncorojakti (S)

International Graduate Course in Veterinary Science and Technology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, 10330 Thailand.
Veterinary Stem Cell and Bioengineering Innovation Center (VSCBIC), Veterinary Pharmacology and Stem Cell Research Laboratory, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, 10330 Thailand.

Watchareewan Rodprasert (W)

Veterinary Stem Cell and Bioengineering Innovation Center (VSCBIC), Veterinary Pharmacology and Stem Cell Research Laboratory, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, 10330 Thailand.

Supansa Yodmuang (S)

Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330 Thailand.
Excellence Center for Advanced Therapy Medicinal Products, King Chulalongkorn Memorial Hospital, Bangkok, 10330 Thailand.

Thanaphum Osathanon (T)

Department of Anatomy, Faculty of Dentistry, Chulalongkorn University, Bangkok, 10330 Thailand.
Center of Excellence in Regenerative Dentistry, Faculty of Dentistry, Chulalongkorn University, Bangkok, 10330 Thailand.

Prasit Pavasant (P)

Department of Anatomy, Faculty of Dentistry, Chulalongkorn University, Bangkok, 10330 Thailand.
Center of Excellence in Regenerative Dentistry, Faculty of Dentistry, Chulalongkorn University, Bangkok, 10330 Thailand.

Sayamon Srisuwatanasagul (S)

Department of Veterinary Anatomy, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, 10330 Thailand.

Chenphop Sawangmake (C)

Veterinary Stem Cell and Bioengineering Innovation Center (VSCBIC), Veterinary Pharmacology and Stem Cell Research Laboratory, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, 10330 Thailand.
Veterinary Clinical Stem Cell and Bioengineering Research Unit, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, 10330 Thailand.
Department of Pharmacology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, 10330 Thailand.

Classifications MeSH